VAR Fundamental Analysis - Varian Medical Systems

No Fundamental Analysis report for VAR not available.

Varian Medical Systems

NYSE:VAR (4/14/2021, 8:19:09 PM)

After market: 177.4 +0.33 (+0.19%)

177.07

-0.04 (-0.02%)

Chartmill FA Rating

GICS SectorN/A

GICS IndustryGroupN/A

GICS IndustryN/A

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0%

Inst Owner Change0%

Ins Owners0.13%

Ins Owner Change0%

Market Cap16.26B

Revenue(TTM)3.12B

Net Income(TTM)277.50M

Analysts54.2

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	45.52
Fwd PE	31.17
P/S	5.22
P/FCF	N/A
P/OCF	N/A
P/B	7.23
P/tB	N/A
EV/EBITDA	36.27

EPS(TTM)3.89

EY2.2%

EPS(NY)5.68

Fwd EY3.21%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS33.95

BVpS24.48

TBVpSN/A

PEG (NY)1.45

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	6.13%
ROE	12.35%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	10.6%
PM (TTM)	8.9%
GM	N/A
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3Y0%

ROICexgc growth 5Y0%

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score5

Asset Turnover0.69

Health

		Industry Rank	Sector Rank
Debt/Equity	0.05
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.51
Quick Ratio	1.19
Altman-Z	5.85

F-Score5

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-17.93%

EPS 3YN/A

EPS 5Y-3.63%

EPS Q2Q%-1.72%

EPS Next Y31.46%

EPS Next 2Y20.53%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-5.88%

Revenue growth 3YN/A

Revenue growth 5Y3.75%

Sales Q2Q%-6.04%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1YN/A

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

Varian Medical Systems / VAR FAQ

What is the ChartMill fundamental rating of Varian Medical Systems (VAR) stock?

ChartMill assigns a fundamental rating of 4 / 10 to VAR.

What is the valuation status of Varian Medical Systems (VAR) stock?

ChartMill assigns a valuation rating of 1 / 10 to Varian Medical Systems (VAR). This can be considered as Overvalued.

Can you provide the profitability details for Varian Medical Systems?

Varian Medical Systems (VAR) has a profitability rating of 6 / 10.

Can you provide the financial health for VAR stock?

The financial health rating of Varian Medical Systems (VAR) is 4 / 10.

Can you provide the expected EPS growth for VAR stock?

The Earnings per Share (EPS) of Varian Medical Systems (VAR) is expected to grow by 31.46% in the next year.

Varian Medical Systems (VAR) Stock Fundamental Analysis